NationalDCGI Suspends Permission To Eye Drop That Claims To Reduce Dependency On Reading GlassesBY PTI
NationalUzbekistan Cough Syrup Deaths: DCGI Alerts States Against Firm That Supplied Raw Material To Marion BiotechBY Outlook News Desk
NationalUzbekistan Deaths: India Starts Probing Marion Biotech, What We Know So Far Of Syrup ControversyBY Outlook News Desk
NationalNasal Vaccine Against Covid-19 To Be Available On CoWIN: All You Need To KnowBY Outlook News Desk
NationalWHO Drew Premature Link Between Death Of Children In Gambia And Indian Syrup: DCGIBY Outlook News Desk
NationalCough Syrup Linked With Death Of Children Not Sold In India, Clarifies CentreBY Outlook News Desk
NationalBharat Biotech's Covid Nasal Vaccine Gets Nod For Emergency Use: All You Need To KnowBY Outlook News Desk
NationalGennova Biopharmaceuticals Is Ready To Roll Out 70 Lakh Doses Of Its Gemcovac-19 vaccineBY PTI
NationalCovid Vaccine Covaxin Cleared For 6-12 Age Group By Drugs Regulator DCGI: ReportsBY Outlook News Desk
NationalBharat Biotech's Intranasal Booster Dose Gets DCGI's Approval For Phase-3 TrialsBY Outlook News Desk
miscellaneousNeed to hold vaccination on war footing, says MP CM Chouhan as inoculation drive for children beginsBY Outlook News Desk
miscellaneousBiological E Aims To Produce 100 Mn Doses/Month Of Corbevax From Feb 2022BY Outlook News Desk
NationalCovovax approval to strengthen immunization efforts in India, lower- & middle-income countries: SIIBY Outlook News Desk
NationalCDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine CovovaxBY Outlook News Desk
miscellaneousPM Calls Retired Lt Gen Hooda, Assures That His Ailing Sister's Request On New Breast Cancer Drug Will Be ConsideredBY Outlook News Desk
NationalBiological E's Corbevax Gets DCGI Approval For Phase 2/3 Clinical Trial On Children, AdolescentsBY Outlook News Desk
NationalZydus Group Likely To Begin Supply Of ZyCoV-D Vaccine By Mid To End SeptemberBY Outlook News Desk
NationalFirst Covid Vaccine For Children Above 12 Years By Zydus Cadila Gets ApprovalBY Outlook News Desk